Drugs give FTSE a lift

By Emily Perryman

04 July 2006 •

The FTSE 100 index has lost 28.6 points, or 0.5%, to 5,856 points this morning, led by AstraZeneca.

Drug giant AstraZeneca has slipped back 1.04% to £32.30 after ING Financial changed its “buy” recommendation to “hold” as it awaits key developments over the next few months. William Morrison has fallen...

To continue reading this article...

Join Professional Adviser

Unlimited access to real-time news, industry insights and market intelligence.
Stay ahead of the curve with spotlights on emerging trends and technologies
Receive breaking news stories straight to your inbox in the daily newsletters.
Make smart business decisions with the latest developments in regulation, investing retirement and protection.
Tap into our community intellignece through our regular Pro Adviser poll.
  Be the first to hear about our events and awards programmes.

Join

Already a Professional Adviser member?

Almost two-thirds against rise in retirement age

Friends Prov to close DB scheme - papers 4th July

More on Investment

Investment

Industry Voice: The responsible investment advice journey

There’s so much noise around responsible investment, but how do you prepare and start to engage with your clients in this area?

Ryan Medlock, Royal London

21 September 2021 • 3 min read

Investment

Partner Content: Could semiconductor super boom match growth of oil-fuelled economies of last century?

The semiconductor industry is predicted to hit sales of around $1trn in 2030, up from $450bn in 2019. We speak to Capital Group about why the sector could power the next decade of global growth – just like the oil industries of the past.

Capital Group

21 September 2021 • 1 min read